Cite
The prognostic and clinical value of p53 upregulated modulator of apoptosis expression in solid tumors: a meta-analysis and TCGA data review.
MLA
Gao, Weifeng, et al. “The Prognostic and Clinical Value of P53 Upregulated Modulator of Apoptosis Expression in Solid Tumors: A Meta-Analysis and TCGA Data Review.” Expert Review of Molecular Diagnostics, vol. 22, no. 8, Aug. 2022, pp. 811–19. EBSCOhost, https://doi.org/10.1080/14737159.2022.2125802.
APA
Gao, W., Yuan, Z., Zhao, X., Wang, S., Lai, S., Ni, K., Zhan, Y., Liu, Z., Liu, L., Xin, R., Yin, X., Zhou, X., Liu, X., Zhang, X., Zhang, Q., Li, G., Wang, W., & Zhang, C. (2022). The prognostic and clinical value of p53 upregulated modulator of apoptosis expression in solid tumors: a meta-analysis and TCGA data review. Expert Review of Molecular Diagnostics, 22(8), 811–819. https://doi.org/10.1080/14737159.2022.2125802
Chicago
Gao, Weifeng, Zhen Yuan, Xuanzhu Zhao, Shuyuan Wang, Sizhen Lai, Kemin Ni, Yixiang Zhan, et al. 2022. “The Prognostic and Clinical Value of P53 Upregulated Modulator of Apoptosis Expression in Solid Tumors: A Meta-Analysis and TCGA Data Review.” Expert Review of Molecular Diagnostics 22 (8): 811–19. doi:10.1080/14737159.2022.2125802.